简介：
Overview
This protocol investigates the antifibrotic activity of human mesenchymal stromal cells infused intravenously after lung injury induced by bleomycin in mice. It allows for the validation of new anti-inflammatory and anti-fibrotic therapies.
Key Study Components
Area of Science
- Neuroscience
- Cell Therapy
- Inflammation
Background
- Bleomycin induces significant lung inflammation and fibrosis.
- Human mesenchymal stromal cells have potential antifibrotic properties.
- Direct lung targeting via endotracheal injection is effective.
- Mouse models are commonly used for preclinical testing.
Purpose of Study
- To evaluate the antifibrotic effects of umbilical cord-derived cells.
- To establish a reproducible model for lung injury.
- To facilitate the testing of new therapeutic strategies.
Methods Used
- Induction of lung injury via endotracheal injection of bleomycin.
- Intravenous infusion of human mesenchymal stromal cells.
- Monitoring of inflammatory and fibrotic responses in mice.
- Use of C57BL/6 mouse strain for consistency in results.
Main Results
- Successful induction of lung inflammation and fibrosis.
- Demonstrated antifibrotic activity of infused cells.
- Validated the model for testing new therapies.
- Established a robust and reproducible experimental protocol.
Conclusions
- The method is effective for studying lung injury and therapy validation.
- Human mesenchymal stromal cells show promise in antifibrotic applications.
- This protocol can be adapted for other therapeutic investigations.
What is the significance of using bleomycin in this study?
Bleomycin is used to induce lung injury, allowing researchers to study inflammatory and fibrotic responses effectively.
How are the human mesenchymal stromal cells administered?
They are infused intravenously after the induction of lung injury.
What mouse strain is used in this protocol?
C57BL/6 mice are used for consistency and reliability in results.
What are the main advantages of this method?
The method allows for rapid targeting of the lungs and minimizes spills in the upper airway.
Can this protocol be adapted for other therapies?
Yes, it can be extended to test various anti-inflammatory and antifibrotic therapies.
Who demonstrates the procedure in the video?
Dr. Fiorenza Orlando, a veterinary doctor, demonstrates the procedure.
繁體中文
